Literature DB >> 1398950

Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice.

M G Stevens1, G W Pugh, L B Tabatabai.   

Abstract

Increased resistance to infection with Brucella abortus 2308 resulted when recombinant murine gamma interferon (rMuIFN-gamma) was given to mice both before and during infection but not when given only before infection. Mice given rMuIFN-gamma had enhanced peritoneal and splenic macrophage bactericidal activity against B. abortus. Treatment of mice with rMuIFN-gamma plus indomethacin did not further enhance resistance to infection or macrophage bactericidal activity compared with that after treatment of mice with rMuIFN-gamma alone.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1398950      PMCID： PMC257479          DOI： 10.1128/iai.60.10.4407-4409.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  20 in total

1.  Recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin in experimental murine tuberculosis.

Authors:  M Khor; D B Lowrie; A R Coates; D A Mitchison
Journal:  Br J Exp Pathol       Date:  1986-08

2.  Increased sensitivity of Corynebacterium parvum-treated mice to toxic effects of indomethacin and lipopolysaccharide.

Authors:  D A Hart
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

3.  Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma.

Authors:  C K Edwards; H B Hedegaard; A Zlotnik; P R Gangadharam; R B Johnston; M J Pabst
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

4.  Characteristics of immunosuppressive macrophages induced in spleen cells by Mycobacterium avium complex infections in mice.

Authors:  H Tomioka; H Saito; Y Yamada
Journal:  J Gen Microbiol       Date:  1990-05

5.  Identification of a virulence factor for Brucella abortus infection in BALB/c mice.

Authors:  G W Pugh; L B Tabatabai; B J Bricker; J E Mayfield; M Phillips; T J McDonald; E S Zehr
Journal:  Am J Vet Res       Date:  1989-06       Impact factor: 1.156

6.  Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan.

Authors:  L D Sibley; L B Adams; J L Krahenbuhl
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

7.  Mycobacterium leprae-burdened macrophages are refractory to activation by gamma interferon.

Authors:  L D Sibley; J L Krahenbuhl
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

8.  Suppression of cellular immunity to Listeria monocytogenes by activated macrophages: mediation by prostaglandins.

Authors:  J C Petit; G Richard; B Burghoffer; G L Daguet
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

9.  Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.

Authors:  T Maier; J H Holda
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

10.  Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages.

Authors:  L D Sibley; S W Hunter; P J Brennan; J L Krahenbuhl
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441
View more
  31 in total

1.  Effect of exogenous interleukin-18 (IL-18) and IL-12 in the course of Brucella abortus 2308 infection in mice.

Authors:  Paolo Pasquali; Rosanna Adone; Louis C Gasbarre; Claudia Pistoia; Franco Ciuchini
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Gamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus.

Authors:  S Segura; C Gamazo; J M Irache; S Espuelas
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

3.  Caspase-1 and Caspase-11 Mediate Pyroptosis, Inflammation, and Control of Brucella Joint Infection.

Authors:  Carolyn A Lacey; William J Mitchell; Alexis S Dadelahi; Jerod A Skyberg
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

4.  Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).

Authors:  D L Hoover; R M Crawford; L L Van De Verg; M J Izadjoo; A K Bhattacharjee; C M Paranavitana; R L Warren; M P Nikolich; T L Hadfield
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.

Authors:  A Al-Mariri; A Tibor; P Mertens; X De Bolle; P Michel; J Godfroid; K Walravens; J J Letesson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

6.  Comparison of cytokine immune responses to Brucella abortus and Yersinia enterocolitica serotype O:9 infections in BALB/c mice.

Authors:  Wenpeng Gu; Xin Wang; Haiyan Qiu; Buyun Cui; Shiwen Zhao; Han Zheng; Yuchun Xiao; Junrong Liang; Ran Duan; Huaiqi Jing
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

7.  Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production.

Authors:  V Weynants; J Godfroid; B Limbourg; C Saegerman; J J Letesson
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

8.  Endogenous gamma interferon mediates resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Lack of a role for natural killer cells in early control of Brucella abortus 2308 infections in mice.

Authors:  D M Fernandes; R Benson; C L Baldwin
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice.

Authors:  Marie-Alice Vitry; Carl De Trez; Stanislas Goriely; Laure Dumoutier; Shizuo Akira; Bernhard Ryffel; Yves Carlier; Jean-Jacques Letesson; Eric Muraille
Journal:  Infect Immun       Date:  2012-09-24       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.